Page results
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
This page explains what extravasation is, and outlines the steps we take when it occurs.
-
Information about the use of deferasirox iron chelation treatment for iron overload.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
The UCLH Lymphoma multidisciplinary team (MDT) provides specialist care for people with lymphoma.
-
Once you have completed treatment for breast cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health. It allows us to identify any signs that…
File results
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23
-
FOI/2024/0667 - Agency/ bank staff, master/neutral vendor/ contract and contact details 2023/24
-
FOI/2024/0668 - Doctors shifts covered by Physician Associates 01/04/2024-01/09/2024
-
FOI/2024/0675 - Direct engagement agency usage/ spend for doctors, nursing and AHP/HSS
-
FOI/2024/0680 - MSP-MV recruitment solution/ contract/ annual spend/ contact details
-
FOI/2024/0681 - Postoperative infections associated with cataract surgery 2019/20-2022/23
-
FOI/2024/0683 - International recruitment for nurses, doctors and AHP/HSS
-
FOI/2024/0684 - Framework agency spend for locum doctors - May/July 2024
-
FOI/2024/0686 - Number of meals stocked/ number of meals thrown away - 01/08/2023-01/08/2024